Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
出版年份 2011 全文链接
标题
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 7, Issue 1, Pages 19-37
出版商
Informa Healthcare
发表日期
2011-12-14
DOI
10.1517/17460441.2012.645534
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?
- (2017) Joel S. Ross et al. JOURNAL OF ALZHEIMERS DISEASE
- Is Brain Amyloid Production a Cause or a Result of Dementia of The Alzheimer's Type?
- (2017) Robert G. Struble et al. JOURNAL OF ALZHEIMERS DISEASE
- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Safety and tolerability of BMS-708163 in a phase II study in mild-to-moderate Alzheimer's disease
- (2011) Stephen Salloway et al. Alzheimers & Dementia
- The gamma-secretase inhibitor BMS-708163 causes dose-dependent reductions in CSF Aβ40 levels in patients with mild-to-moderate Alzheimer's disease (AD)
- (2011) Charles Albright et al. Alzheimers & Dementia
- 2011 Alzheimer’s disease facts and figures
- (2011) Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
- (2011) Alberto Lleo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
- (2011) Bruno P. Imbimbo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Functional and Topological Analysis of Pen-2, the Fourth Subunit of the γ-Secretase Complex
- (2011) Leen Bammens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A placebo-controlled, ascending, multiple-dose study to evaluate the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-708163 in healthy young and elderly subjects
- (2010) Jun-Sheng Wang et al. Alzheimers & Dementia
- APP-selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease
- (2010) Sally Schroeter et al. Alzheimers & Dementia
- A study to evaluate the effects of single oral doses of BMS-708163 in the cerebrospinal fluid of healthy young men
- (2010) Gary Tong et al. Alzheimers & Dementia
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- Emerging role of Notch signaling in epidermal differentiation and skin cancer
- (2010) John Panelos et al. CANCER BIOLOGY & THERAPY
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
- (2010) James A. Duce et al. CELL
- REVIEW: γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State
- (2010) Francesco Panza et al. CNS Neuroscience & Therapeutics
- Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
- (2010) V. Frisardi et al. Current Alzheimer Research
- γ-Secretase as a Therapeutic Target in Alzheimers Disease
- (2010) Guardia-Laguarta C. et al. CURRENT DRUG TARGETS
- Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease
- (2010) Francesco Panza et al. Immunotherapy
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
- (2010) Gen He et al. NATURE
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- p53 Is Regulated by and Regulates Members of the γ-Secretase Complex
- (2010) Frédéric Checler et al. Neurodegenerative Diseases
- Amyloid beta 42 peptide (A 42)-lowering compounds directly bind to A and interfere with amyloid precursor protein (APP) transmembrane dimerization
- (2010) L. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport: Fig. 1
- (2010) Keith A. Vossel et al. SCIENCE
- Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor
- (2010) Kevin W. Gillman et al. ACS Medicinal Chemistry Letters
- Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease
- (2009) Davide Seripa et al. AGEING RESEARCH REVIEWS
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Presenilin-dependent regulated intramembrane proteolysis and γ-secretase activity
- (2009) J. V. McCarthy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease
- (2009) Francesco Panza et al. DRUGS & AGING
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway
- (2009) Z. V. Goodger et al. JOURNAL OF CELL SCIENCE
- Recent Advances in the Identification of γ-Secretase Inhibitors To Clinically Test the Aβ Oligomer Hypothesis of Alzheimer’s Disease
- (2009) Anthony F. Kreft et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological evidences for DFK167-sensitive presenilin-independent γ-secretase-like activity
- (2009) Jean Sevalle et al. JOURNAL OF NEUROCHEMISTRY
- -Secretase Inhibition Reduces Spine Density In Vivo via an Amyloid Precursor Protein-Dependent Pathway
- (2009) T. Bittner et al. JOURNAL OF NEUROSCIENCE
- Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease
- (2009) R. L. Martone et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575
- (2009) Monica Garcia-Alloza et al. Molecular Neurodegeneration
- The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons
- (2009) A. Thathiah et al. SCIENCE
- -Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease
- (2009) L. Serneels et al. SCIENCE
- P1-017: Comparison of cisternal and lumbar cerebrospinal fluid amyloid-beta concentrations following oral administration of LY450139 dihydrate to Beagle dogs
- (2008) Patrick J. Cocke et al. Alzheimers & Dementia
- P3-101: GSI-953, a potent and selective gamma-secretase inhibitor, modulates Abeta peptides in mice and humans: Translating the PK/PD biomarker relationships in different biological compartments between rodent and human
- (2008) Hong Wan et al. Alzheimers & Dementia
- P4-366: GSI-953, a potent and selective gamma-secretase inhibitor: Modulation of beta-amyloid peptides and plasma and cerebrospinal fluid pharmacokinetic/pharmacodynamic relationships in humans
- (2008) Glen Frick et al. Alzheimers & Dementia
- Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
- (2008) Ludovico Minati et al. American Journal of Alzheimers Disease and Other Dementias
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- In vitro reconstitution of γ-secretase activity using yeast microsomes
- (2008) Sosuke Yagishita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent Progress in the Medicinal Chemistry of γ-Secretase Inhibitors
- (2008) Richard Olson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- γ-Secretase Modulation and its Promise for Alzheimers Disease: a Medicinal Chemistry Perspective
- (2008) Ilaria Peretto et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Activity of γ -Secretase on Substrates Other than APP
- (2008) Alberto D. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glu332in the Nicastrin Ectodomain Is Essential for γ-Secretase Complex Maturation but Not for Its Activity
- (2008) Lucía Chávez-Gutiérrez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cryoelectron Microscopy Structure of Purified γ-Secretase at 12 Å Resolution
- (2008) Pamela Osenkowski et al. JOURNAL OF MOLECULAR BIOLOGY
- Notch: from neural development to neurological disorders
- (2008) Justin D. Lathia et al. JOURNAL OF NEUROCHEMISTRY
- Dynamics of A Turnover and Deposition in Different -Amyloid Precursor Protein Transgenic Mouse Models Following -Secretase Inhibition
- (2008) D. Abramowski et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Therapeutic Strategies for Alzheimer’s Disease
- (2008) Donna M. Barten et al. MOLECULAR NEUROBIOLOGY
- Substrate-targeting γ-secretase modulators
- (2008) Thomas L. Kukar et al. NATURE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- β-Secretase as a therapeutic target for Alzheimer’s disease
- (2008) Arun K. Ghosh et al. Neurotherapeutics
- Deficiency of Aph1B/C- -secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment
- (2008) T. Dejaegere et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease
- (2008) Thorsten Müller et al. PROGRESS IN NEUROBIOLOGY
- Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
- (2003) H. F. Dovey et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started